EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Overexpression of Apolipoprotein A-I Alleviates Insulin Resistance in MASLD Mice Through the PPARα Pathway

Yifan Wang, Yudian Zhang iD, Yutong Wang

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26031051 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Yifan Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Municipal Laboratory for Liver Protection and Regulation of Regeneration, Department of Cell Biology, School of Basic Medical Sciences, Capital Medic…. Hauptthemen laut MEDLINE: Insulin Resistance, PPAR alpha, Apolipoprotein A-I, Fatty Liver. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, R&D Program of Beijing Municipal Education Commission, R&D Program of Beijing Municipal Education Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Insulin resistance (IR) is one of the important causes of metabolic dysfunction-associated steatotic liver disease (MASLD). Apolipoprotein A-I (apoA-I) is secreted primarily by hepatocytes and plays an essential role in reverse cholesterol transport. Our previous studies revealed that apoA-I can mitigate the progression of metabolic dysfunction-associated steatohepatitis (MASH). However, there is no clear evidence to explain the relationship between apoA-I and IR. Here, we investigated the effects of apoA-I overexpression on IR in both HepG2 cells and mice. In vitro experiment results revealed that apoA-I overexpression can promote cellular glucose uptake in oleic acid-induced IR in HepG2 cells. High-fat, high-cholesterol, and high-fructose diets were used to induce IR in mice. The results showed that apoA-I overexpression improved glucose tolerance, reduced serum insulin levels, and ameliorated IR in diet-induced MASLD mice. Moreover, apoA-I promoted the expression of peroxisome proliferator-activated receptor α (PPARα) in the nucleus both in vitro and in vivo. In conclusion, apoA-I could alleviate MASLD by reducing IR in mice and might exert this effect through the PPARα pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin ResistancePPAR alphaApolipoprotein A-IFatty LiverAnimalsMiceHumansHep G2 CellsMaleSignal TransductionDiet, High-FatGlucoseMice, Inbred C57BLInsulinDisease Models, Animal

Stichwörter der Autor:innen

apolipoprotein A-Iinsulin resistancemetabolic dysfunction-associated steatotic liver diseaseperoxisome proliferator-activated receptor α

Substanzen

PPAR alphaApolipoprotein A-IGlucoseInsulinPpara protein, mouse

Autor:innen und Institutionen

  • Municipal Laboratory for Liver Protection and Regulation of Regeneration, Department of Cell Biology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China.

ORCID-Profile: Yudian Zhang

Förderung

  • National Natural Science Foundation of China
  • R&D Program of Beijing Municipal Education Commission
  • R&D Program of Beijing Municipal Education Commission

Zitieren

APA

Wang, Y., Zhang, Y., & Wang, Y. (2025). Overexpression of Apolipoprotein A-I Alleviates Insulin Resistance in MASLD Mice Through the PPARα Pathway. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26031051

Vancouver

Wang Y, Zhang Y, Wang Y. Overexpression of Apolipoprotein A-I Alleviates Insulin Resistance in MASLD Mice Through the PPARα Pathway. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26031051

BibTeX
@article{Wang2025,
  author = {Wang, Yifan and Zhang, Yudian and Wang, Yutong},
  title = {Overexpression of Apolipoprotein A-I Alleviates Insulin Resistance in MASLD Mice Through the PPARα Pathway},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26031051}
}
Kostenlos starten →